Volume 2.14 | Apr 10

PUBLICATIONS (Ranked by impact factor of the journal)

MiR145 Targets the SOX9/ADAM17 Axis to Inhibit Tumor Initiating Cells and IL-6-Mediated Paracrine Effects in Head and Neck Cancer
Researchers report that ALDH1+CD44+ head and neck squamous cell carcinoma (HNC) cells express reduced levels of miR145. SPONGE-mediated inhibition of miR-145 was sufficient to drive tumor-initiating characteristics in non-tumor-initiating cells (TICs)/ ALDH1-CD44-negative HNC cells. [Cancer Res]
Abstract | Full Article

Inertial Focusing for Tumor Antigen-Dependent and -Independent Sorting of Rare Circulating Tumor Cells
Investigators described an inertial focusing-enhanced microfluidic circulating tumor cell (CTC) capture platform, termed “CTC-iChip,” that is capable of sorting rare CTCs from whole blood at 10⁷ cells/s. [Sci Transl Med] Abstract | Press Release

Photochemical Internalization (PCI) of Immunotoxins Targeting CD133 Is Specific and Highly Potent at Femtomolar Levels in Cells with Cancer Stem Cell Properties
CD133 is a putative cancer stem cell marker for a number of different cancers and is suggested to be a therapeutic target. Researchers employed PCI, a minimally invasive method for light-controlled, specific delivery of membrane-impermeable macromolecules from endocytic vesicles to the cytosol, to specifically target CD133-positive cancer cells. [J Control Release] Abstract

TTC5 Is Required to Prevent Apoptosis of Acute Myeloid Leukemia Stem Cells
Using a screening strategy, researchers identified the tetratricopeptide repeat motif protein, Tetratricopeptide repeat domain 5 (TTC5) as required for the survival of human acute myeloid leukemia cells. [Cell Death Dis] Full Article

FK506 Binding Protein 51 Positively Regulates Melanoma Stemness and Metastatic Potential
Researchers hypothesized a role for FK506 binding protein 51 (FKBP51) in melanoma invasive behavior. Their study provides evidence that the genetic programs of cancer stemness and invasiveness overlap in melanoma, and that FKBP51 plays a pivotal role in sustaining such a program. [Cell Death Dis] Full Article

Proteomic Analysis Reveals that CD147/EMMPRIN Confers Chemoresistance in Cancer Stem Cell-Like Cells
Investigators presented a systematic analysis of the cell-surface proteome using a cancer stem cell-like cell line derived from MDA-MB453 breast cancer cells which exhibited a CD44⁺/CD24^– phenotype and chemoresistance. [Proteomics] Abstract

Rapamycin Inhibits FBXW7 Loss-Induced Epithelial-Mesenchymal Transition and Cancer Stem Cell-Like Characteristics in Colorectal Cancer Cells
The authors explored whether FBXW7 plays any role in metastatic process. They showed that depletion of FBXW7 induces epithelial-mesenchymal transition in human colon cancer cells along with the increase in cell migration and invasion. Moreover, FBXW7 deficiency promotes the generation of colon cancer stem-like cells in tumor-sphere culture. [Biochem Biophys Res Commun] Abstract

NVP-LDE-225 (Erismodegib) Inhibits Epithelial-Mesenchymal Transition and Human Prostate Cancer Stem Cell Growth in NOD/SCID IL2Rγ Null Mice by Regulating Bmi-1 and MicroRNA-128
Scientists examined the molecular mechanisms, by which NVP-LDE-225/Erismodegib (smoothened inhibitor) regulates stem cell characteristics and tumor growth in prostate cancer. [Oncogenesis] Full Article

PML-Mediated Signaling and Its Role in Cancer Stem Cells
The authors summarized and discussed the promyelocytic leukemia (PML)-mediated signaling pathways in cancers and their potential roles in regulating cancer stem cells. [Oncogene] Abstract

Visit our reviews page to see a complete list of reviews in the cancer stem cell research field.

ASH Awards First Bridge Grants to Sustain Critical Hematology Research During Current Period of Funding Restrictions
The American Society of Hematology (ASH) announced the first recipients of the ASH Bridge Grants, a new award program designed to help hematologists continue their critical blood disease research amid severe funding reductions for the National Institutes of Health. [American Society of Hematology] Press Release

Researchers to Develop Next Generation Immunotherapy for Children with Deadly Solid Tumors
Researchers at the Children’s Hospital of Philadelphia, the University of Pennsylvania, and the Primary Children’s Medical Center of Salt Lake City received a $550,000 collaborative grant to test next generation T-cell immunotherapy strategies in children with neuroblastoma. The awardees were selected within a rigorous peer-review process through a new initiative called ACT FAST (Adoptive Cell Therapy For Adolescent/pediatric Solid Tumor), which is spearheaded by Solving Kids’ Cancer. [Solving Kids’ Cancer] Press Release

Stem Cell Therapeutics Completes Trillium Merger and Issues Stock Options
Stem Cell Therapeutics Corp. announced that it has completed its merger with Trillium Therapeutics Inc. The shareholders of Trillium voted overwhelmingly to support the merger. [Stem Cell Therapeutics Corp.]
Press Release

NEW The Jackson Laboratory: Modeling Human Malignancy with Patient-Derived Xenograft Cancer Models
April 18, 1:00PM (ET in US)
Webinar

NEW The Bone Marrow Niche, Stem Cells, and Leukemia: Impact of Drugs, Chemicals, and the Environment
May 29-31, 2013
New York, United States

Visit our events page to see a complete list of events in the cancer stem cell community.

Postdoctoral Scientist (Eli Lilly)

PhD Studentship Opportunity (University of East Anglia)

Postdoctoral Fellow – Epigenetics (Structural Genomics Consortium at University of Toronto)

PhD Student (Universitätsklinikum Carl Gustav Carus)

PhD Studentship – Signal Transduction and Cancer Research (Department of Medicine, McGill University)

Faculties in Cancer Biology & Immunotherapy (Huzhou University School of Medicine)

Postdoctoral Researcher – Pancreatic Cancer (University of Notre Dame, Department of Biological Sciences)

Postdoctoral Associate (University of California, Berkeley)


Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Have we missed an important article or publication in Cancer Stem Cell News? Click here to submit!